Esken Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.30 Cr
- Paid Up Capital ₹ 1.59 Cr
- Company Age 32 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 2.84 Cr
- Revenue Growth -51.95%
- Profit Growth -74.72%
- Ebitda -364.43%
- Net Worth -46.31%
- Total Assets -11.85%
About Esken Pharmaceuticals
Esken Pharmaceuticals Limited (EPL) is a Public Limited Indian Non-Government Company incorporated in India on 07 July 1992 and has a history of 32 years and ten months. Its registered office is in Mahesana, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 6.30 Cr and a paid-up capital of Rs 1.59 Cr.
The company has closed loans amounting to ₹2.84 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ashishkumar Patel, Pranavkumar Patel, and Nigamkumar Patel serve as directors at the Company.
Company Details
- Location
Mahesana, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231GJ1992PLC017941
- Company No.
017941
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
07 Jul 1992
- Date of AGM
25 Feb 2023
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Pharma
Esken Pharmaceuticals Limited
Explore comprehensive data for Esken Pharmaceuticals Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Esken Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashishkumar Patel  | Whole-Time Director | 06-Jul-1997 | Current |
| Pranavkumar Patel | Whole-Time Director | 06-Jul-1997 | Current |
| Nigamkumar Patel | Whole-Time Director | 06-Jul-1997 | Current |
Financial Performance of Esken Pharmaceuticals.
Esken Pharmaceuticals Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 51.95% decrease. The company also saw a substantial fall in profitability, with a 74.72% decrease in profit. The company's net worth observed a substantial decline by a decrease of 46.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Esken Pharmaceuticals?
In 2019, Esken Pharmaceuticals had a promoter holding of 15.79% and a public holding of 84.21%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Spielberg Beverages Private LimitedPranavkumar Patel is a mutual person
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹2.84 Cr
Charges Breakdown by Lending Institutions
- Others : 2.25 Cr
- The Co-Operative Bank Of Mehsana Limited : 0.50 Cr
- The Co-Op Bank Of Mehsana Ltd. : 0.09 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 May 2016 | Others | ₹2.25 Cr | Satisfied |
| 26 Feb 2009 | The Co-Operative Bank Of Mehsana Limited | ₹2.50 M | Satisfied |
| 05 Jul 2008 | The Co-Operative Bank Of Mehsana Limited | ₹2.50 M | Satisfied |
| 11 Jun 2007 | The Co-Op Bank Of Mehsana Ltd. | ₹0.90 M | Satisfied |
How Many Employees Work at Esken Pharmaceuticals?
Esken Pharmaceuticals has a workforce of 3 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Esken Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Esken Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Esken Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Esken Pharmaceuticals Limited last Annual general meeting of members was held on 25 Feb 2023 as per latest MCA records.
- Balance Sheet
Esken Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Ahmedabad.
- Charges
A charge registered on 23 May 2016 via Charge ID 100028731 with Others was fully satisfied on 03 Sep 2020.
- Charges
A charge with Others amounted to Rs. 2.25 Cr with Charge ID 100028731 was registered on 23 May 2016.
- Charges
A charge registered on 26 Feb 2009 via Charge ID 10147777 with The Co-Operative Bank Of Mehsana Limited was fully satisfied on 18 May 2016.
- Charges
A charge registered on 05 Jul 2008 via Charge ID 10112748 with The Co-Operative Bank Of Mehsana Limited was fully satisfied on 18 May 2016.
Frequently asked questions
What is the Incorporation or founding date of Esken Pharmaceuticals Limited?
Esken Pharmaceuticals Limited was incorporated on 07 Jul 1992.
What is authorized share capital and paid-up capital of Esken Pharmaceuticals Limited?
The authorized share capital of Esken Pharmaceuticals Limited is ₹ 6.30 Cr and paid-up capital is ₹ 1.59 Cr.
Who are the current board members & directors of Esken Pharmaceuticals Limited?
Currently 3 directors are associated with Esken Pharmaceuticals Limited.
- Ashishkumar Tribhovandas Patel
- Pranavkumar Manilal Patel
- Nigamkumar Babulal Patel
What is the registered address of Esken Pharmaceuticals Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Esken Pharmaceuticals Limited is 322 G I D C Phase Iidediasan Mehsana India, Gujarat, 384001.
What is the corporate identification number (CIN) and company number of Esken Pharmaceuticals Limited?
The corporate identification number (CIN) of Esken Pharmaceuticals Limited is U24231GJ1992PLC017941 and the company number is 017941 as per Ministry of Corporate Affairs (MCA).
What is the official website of Esken Pharmaceuticals Limited?
The Official website of Esken Pharmaceuticals Limited is https://www.eskenpharmaceuticals.com
What has been the recent revenue trend for Esken Pharmaceuticals Limited?
According to the financial reports for the fiscal year 2020, the revenue trend for Esken Pharmaceuticals Limited has fallen by -51.95%.
How many employees does Esken Pharmaceuticals Limited currently have?
As Per 2020 financial reports, 3 employees are currently employed by Esken Pharmaceuticals Limited.
What change has been observed in the net worth of Esken Pharmaceuticals Limited, and by what percentage?
The financial reports for the fiscal year 2020 indicates that The net worth of Esken Pharmaceuticals Limited has experienced an downturn of -46.31%.
When was the last Balance Sheet of Esken Pharmaceuticals Limited filed with the ROC?
The most recent Balance Sheet for Esken Pharmaceuticals Limited was filed with the ROC on 31 Mar 2022.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
BP
Bharatkumar PatelManaging DirectorMP
Manilal PatelDirector
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Vadodara, Gujarat, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India